Skip to Main Content

Paper Details

Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.
ACS Cent Sci
29
2021
Author NameAffiliation
Daniel Picard
Daniel Picard
Daniel Picardand Clinical Immunology, University Hospital Dusseldorf
Marc Remke
Marc Remke
Marc Remkeand Clinical Immunology, University Hospital Dusseldorf
Tobias WeissUniversity Hospital Zurich and University of Zurich
Michael WellerUniversity Hospital Zurich and University of Zurich
Claudia C FariaInstituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
Claudia C FariaHospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN) EPE
  • 1 - 10

Datasets

Release 1.2